Vaccine specialist Genocea Biosciences Inc (NASDAQ:GNCA) struck a research deal with Dana-Farber Cancer Institute and Harvard Medical School to study cancer immunology. Under the March 5 alliance, researchers will use Genocea Biosciences Inc (NASDAQ:GNCA)’s proprietary T cell antigen discovery platform to find antigens that correlate with an anti-tumor immune response in melanoma patients. Genocea Biosciences Inc (NASDAQ:GNCA) stock performance was 23.28% in last session and … Continue reading Hot Biotech Bullish Stocks: Genocea Biosciences (NASDAQ:GNCA), Esperion Therapeutics (NASDAQ:ESPR), Anacor Pharmaceuticals (NASDAQ:ANAC), CEL-SCI (NYSEMKT:CVM)